VOR - Vor Biopharma Inc.
15.12
0.560 3.704%
Share volume: 544,630
Last Updated: 03-06-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.19%
PREVIOUS CLOSE
CHG
CHG%
$14.56
0.56
0.04%
View ratios
| Fiscal Date | 12-31-2024 | 03-31-2025 | 09-30-2025 | |
|---|---|---|---|---|
| Fiscal Quarter | Q4 2024 | Q1 2025 | Q3 2025 | |
| Report Date | 03-20-2025 | 05-14-2025 | 11-13-2025 | |
| Assets | ||||
| Total Assets | 142.891 M | 109.312 M | 176.237 M | |
| Current Assets | 96.507 M | 64.847 M | 172.486 M | |
| Inventories | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 380.000 K | 297.000 K | 1.277 M | |
| Short Term Investments | 9.977 M | 9.988 M | 10.000 M | |
| Total Receivables | 0.000 | 0.000 | 0.000 | |
| Current Cash | 81.949 M | 50.047 M | 160.462 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 6.581 M | 5.986 M | 271.000 K | |
| Other Assets | 39.803 M | 38.479 M | 3.480 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||
| Total Liabilities and shareholders’ equity | 142.891 M | 109.312 M | 176.237 M | |
| Total liabilities | 46.227 M | 43.243 M | 2.402 B | |
| Total current liabilities | 18.612 M | 16.727 M | 18.839 M | |
| Accounts Payable | 1.505 M | 3.732 M | 885.000 K | |
| Other liabilities | 27.615 M | 26.516 M | 2.383 B | |
| Current long term debt | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 27.615 M | 26.516 M | 2.383 B | |
| Minority interest | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 96.664 M | 66.069 M | -2.225 B | |
| Common stock | 553.636 M | 555.526 M | 650.334 M | |
| Retained earnings | -456.994 M | -489.480 M | -2.876 B |